Pyrimidinone compounds as calcilytics

Details for Australian Patent Application No. 2004230903 (hide)

Owner NPS Pharmaceuticals, Inc. GlaxoSmithKline

Inventors Luengo, Juan; Fox, John; Geoffroy, Otto; Marquis, Robert; Shcherbakova, Irina V.; Yamashita, Dennis Shinji; Balandrin, Manuel F.; Wang, Wenyong; Huang, Guangfei

Agent Spruson & Ferguson

Pub. Number AU-A-2004230903

PCT Pub. Number WO2004/092120

Priority 60/460,859 07.04.03 US; 60/479,323 18.06.03 US

Filing date 7 April 2004

Wipo publication date 28 October 2004

International Classifications

C07D 239/36 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092120 Priority application(s): WO2004/092120

13 April 2006 Change of Name(s) of Applicant(s), Section 104

  NPS Pharmaceuticals, Inc.; GlaxoSmithKline The name of the applicant has been changed to NPS Pharmaceuticals, Inc.; SmithKline Beecham Corporation

10 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230905-Plural component spray gun for fast setting materials

2004230899-Plasma reactor and process for producing lower-energy hydrogen species